Industry Calls on FDA to Be More Detailed on RWD in Confirmatory Evidence Guidance

The FDA’s guidance on showing effectiveness through a single trial plus confirmatory evidence is off to a good start in offering direction on leveraging real-world data (RWD), but providing more specifics would be highly beneficial, industry comments say as comments close on the agency’s draft guidance.
Source: Drug Industry Daily